Status: Ongoing First registered on: 23/12/2019
Last updated on: 23/12/2019
1. Study identification
EU PAS Register NumberEUPAS32899
Official titleSevere Asthma Super-Responders Delphi Exercise
Study title acronym
Study typeObservational study
Brief description of the studyThis study aims to survey health care professionals in multiple countries to define a consensus-based definition of a severe asthma ‘super-responder’. Primary objectives of this study are to follow a Delphi process to define an international consensus-based definition of a ‘super-responder’, targeting health care professionals in multiple countries who treat severe asthma. The Delphi process will comprise of two or three iterative rounds of electronic surveys to gather anonymised opinions on the definition of a super-responder. De-identified data will be collected after each round and summary statistics completed to identify if consensus has been reached for each topic.
Was this study requested by a regulator?No
Is the study required by a Risk Management Plan (RMP)? Not applicable
Regulatory procedure number (RMP Category 1 and 2 studies only)
Other study registration identification numbers and URLs as applicable
2. Research centres and Investigator details
Coordinating study entity
Centre to which the investigator belongsOPRI Pte Ltd
Department/Research groupObservational and Pragmatic Research Institute Pte Ltd
Organisation/affiliationOPRI Pte Ltd
Website/Homepagewww.opri.sg
Details of (Primary) lead investigator
Title Professor
Last name Upham
First name John
Is this study being carried out with the collaboration of a research network?
Yes

Respiratory Effectiveness Group (REG)
Other centres where this study is being conducted
Not applicable (single centre)

Countries in which this study is being conducted
International study

Argentina
Australia
Belgium
Bulgaria
Canada
Colombia
Denmark
Estonia
Finland
France
Germany
Greece
Iceland
India
Italy
Kuwait
Mexico
Netherlands
New Zealand
Portugal
Saudi Arabia
Singapore
Spain
Taiwan
Thailand
United Arab Emirates
United Kingdom
United States
3. Study timelines: initial administrative steps, progress reports and final report
PlannedActual
Date when funding contract was signed18/06/201918/06/2019
Start date of data collection04/09/201904/09/2019
Start date of data analysis03/02/2020
Date of interim report, if expected
Date of final study report21/02/2020
4. Sources of funding
Please provide estimates of the percentage of funding by source for this study
Names(s)Approximate % funding
Pharmaceutical companies
Charities
Government body
Research councils
EU funding scheme
OtherObservational Pragmatic Research Institute (OPI)100
5. Contact details for enquiries
Scientific Enquiries
Title Professor
Last name Upham
First name John
Address line 1Translational Research Institute
Address line 237 Kent Street Woolloongabba 
Address line 3 
CityBrisbane, QLD 
Postcode 
CountryAustralia
Phone number (incl. country code)61734438065 
Alternative phone number 
Fax number (incl. country code) 
Email address chantal@opri.sg
Public Enquiries
Title Professor 
Last name Upham 
First name John 
Address line 1Translational Research Institute 
Address line 237 Kent Street Woolloongabba 
Address line 3 
CityBrisbane, QLD 
Postcode 
CountryAustralia 
Phone number (incl. country code)61734438065 
Alternative phone number 
Fax number (incl. country code) 
Email address chantal@opri.sg 
Top